-
Labarai masu kayatarwa | Mafi Girman Kayan Samar da Semaglutide API na China Ya Wuce Binciken FDA na Amurka
Daga 26 ga Agusta zuwa 30 ga Agusta, 2024, wurin samar da peptide na JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., ya yi nasarar shawo kan wani binciken da Hukumar Abinci da Magunguna ta Amurka (FDA) ta gudanar. Binciken ya kunshi muhimman wurare...Kara karantawa -
2024 CPHI Milan Pharmaceutical Nunin Recap
01. Baje kolin Baje kolin A ranar 8 ga Oktoba, 2024 CPHI Worldwide Pharmaceutical Exhibition ya fara a Milan. A matsayin daya daga cikin muhimman abubuwan da suka faru na shekara-shekara a masana'antar harhada magunguna ta duniya, ya jawo mahalarta daga kasashe da yankuna 166. Da over...Kara karantawa -
Labarai masu kayatarwa | JYMed's Liraglutide API yana karɓar Takaddun shaida na WC
A ranar 12 ga Oktoba, 2024, JYMed's Liraglutide API ya sami takaddun Tabbacin Rubuce-rubuce (WC), wanda ke nuna muhimmin mataki ga nasarar fitar da API zuwa kasuwar EU. WC (Tabbacin Rubuce-rubuce)...Kara karantawa -
Labari Mai Dadi: JYMed's Leuprorelin Acetate Ya Wuce Binciken Rijistar Magunguna
Kwanan nan, JYMed Technology Co., Ltd. ya sanar da cewa Leuprorelin Acetate, wanda reshensa na Hubei JX Bio-Pharmaceutical Co., Ltd. ya samar, ya yi nasarar wuce binciken rajistar magunguna. Kasuwar Magani ta asali...Kara karantawa -
Taya murna JYMed's Tirzepatide Ya Kammala Shigar US-DMF
JYMed Technology Co., Ltd. ya yi farin cikin sanar da cewa samfurinsa, Tirzepatide, ya yi nasarar kammala rajistar Drug Master File (DMF) tare da US FDA (Lambar DMF: 040115) kuma ya karbi Amincewar FDA ...Kara karantawa -
JYMed ya halarci PCT 2024 a Shanghai
PCT2024 Babban Taron Fasaha na Kula da Lafiya & Nunin wani lamari ne mai matukar tasiri a yankin Asiya-Pacific, yana mai da hankali kan musayar fasaha da nune-nune a cikin masana'antar samfuran kulawa ta sirri.Taron zai rufe fannoni daban-daban na masana'antar kulawa ta sirri, gami da fasaha a cikin ...Kara karantawa -
JYMed Peptide yana gayyatar ku don halartar Nunin Kayan Kayan Kayan Kaya na Koriya ta 2024
Wuri: Cibiyar Baje kolin Koriya ta Duniya Kwanan wata: Yuli 24-26, 2024 Time: 10:00 AM - 5:00 PM Adireshin: Cibiyar Nunin COEX Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics shine jagorancin ƙungiyar baje kolin kasa da kasa a cikin abubuwan kulawa na sirri ...Kara karantawa -
Sabuwar Dokar Ka'ida
1. Sabbin Dokokin Rijistar FDA don Kayan Kayan Kayan Kayan Aiki na Amurka Ba tare da Rijistar FDA ba Za a Haramta Daga Siyarwa. Bisa ga Zamantakewar Dokar Kayayyakin Kayan Aiki na 2022, wanda Shugaba Biden ya sanya wa hannu a ranar 29 ga Disamba, 2022, duk kayan kwalliyar da aka fitar zuwa Amurka dole ne su zama FDA. - yi rijista...Kara karantawa -
Sanarwa Holiday Festival
Da fatan za a sanar da mu cewa ofishinmu zai rufe daga 4 ga Fabrairu zuwa Fabrairu 18 saboda bikin bazara. Za a karɓi kowane umarni amma ba za a sarrafa shi ba har sai Fabrairu.19, ranar kasuwanci ta farko bayan Bikin bazara. Yi hakuri ga duk wani rashin jin daɗi da aka haifar.Kara karantawa -
2023 API ɗin 88th CINA
Bayani game da JYMed a 2023 API CHINA 【on-site】 Karkashin jagorancin Mataimakin Janar Manaja Zhi Qin, Shenzhen JYMed Technology Co., Ltd. (nan gaba ana kiranta da JYMed) sun halarci wannan babban nunin. JYMed ya nuna samfurori masu fa'ida Semaglutide, Liraglutide, Tirzepatide, O ...Kara karantawa -
Barka da saduwa da mu a nunin API a Qindao China JYMed stock: N4K32
Kara karantawa -
JYMed ya taru tare da ku a PCHi
Bayan shekaru biyu na sa rai, an gudanar da bikin baje kolin kayayyakin kwaskwarima na kasa da kasa na kasa da kasa da na gida da na gida (PCHi) a gidan baje koli na Guangzhou Canton a ranar 15-17 ga Fabrairu, 2023. ...Kara karantawa -
Semeglutide API na Shenzhen JYMed yarda da farkon tsari na gida NMPA da kuma Rajista a US FDA (DMF No. 036009) tare da matsayi "A".
A cikin Mayu 2022, Shenzhen JYMed Technology Co., Ltd. (wanda ake kira JYMed peptide) ya ƙaddamar da aikace-aikacen rajistar semaglutide API zuwa Hukumar Abinci da Magunguna ta Amurka (FDA) (lambar rajista DMF: 036009), Ya wuce. bitar mutunci, da kuma halin da ake ciki yanzu...Kara karantawa -
Copper Peptides: Fa'idodin Kula da Fata da Gashi da Yadda ake Amfani da su
Mun haɗa da samfuran da muke tsammanin masu karatunmu za su sami amfani. Za mu iya samun ƙaramin kwamiti idan kun yi siyayya ta hanyar haɗin yanar gizo akan wannan shafin. Wannan shine tsarin mu. Peptides sune amino acid da ke faruwa a zahiri waɗanda ke taimakawa samar da collagen da elastin, ƙwayoyin haɗin gwiwa guda biyu waɗanda ke da alhakin s ...Kara karantawa -
Ozempic (Semaglutide) Allurar: Amfani, Tasirin Side, Sashi
Erica Prouty, PharmD, ƙwararren masani ne da ke taimaka wa marasa lafiya da magunguna da sabis na kantin magani a Arewacin Adams, Massachusetts. A cikin binciken dabba ba na ɗan adam ba, an nuna semaglutide don haifar da ciwan thyroid C-cell a cikin rodents. Duk da haka, ba a sani ba ko wannan hadarin ya shafi mutane ....Kara karantawa -
Rarraba fatty acids a cikin gano peptide da magungunan furotin
Na gode da ziyartar Nature.com. Sigar burauzar da kuke amfani da ita tana da iyakacin tallafin CSS. Don ƙwarewa mafi kyau, muna ba da shawarar ku yi amfani da sabuntar burauza (ko kuma musaki Yanayin dacewa a cikin Internet Explorer). A halin yanzu, don tabbatar da ci gaba da goyon baya, za mu ba da shafin ba tare da s ...Kara karantawa -
Ƙwararren ƙwayoyi na Class I na JYMed sun sami ci gaba mai mahimmanci, Laipushutai ana sa ran ya zama layin farko na magungunan UC.
A ranar 29 ga Yuni, 2017, ci gaban Laipushutai, aji na ƙwararrun likitanci tare da haɓaka haɗin gwiwar JYMed da Guangzhou Linkhealth Medical Technology Co., Ltd., ya sami ci gaba sosai. CFDA ta karɓi sanarwar IND na miyagun ƙwayoyi. JYMed da Guangzhou Lin...Kara karantawa -
Labarai & Abubuwan da ke faruwaSashen samfuran Peptide a cikin JYMed sun wuce binciken yanar gizo ba tare da lahani ba daga FDA.
Da farin ciki taya murna ga Rukunin Kayayyakinmu na Polypeptide don nasarar cin nasarar binciken US FDA akan rukunin yanar gizon tare da “lalacewar sifili”! Wucewa binciken yanar gizo na FDA tare da "lalacewar sifili" babban lamari ne a tarihin ci gaban cGMP ɗin mu. Ba wai kawai yana nufin API ɗinmu yana da obt ...Kara karantawa